Switch to:
More From Other Websites
Teva Has a Targeted Strategy to Expand in Major Growth Markets Sep 30 2016
Amgen Migraine Drug Likely To Beat Eli Lilly, Alder, Teva To Market Sep 29 2016
Deutsche Bank, Wells Fargo Tumble into 52-Week Low Clubs Sep 29 2016
3:52 pm Teva Pharma: Generic Epzicom tablets now available in the US Sep 29 2016
Why Teva and Regeneron Entered Collaboration Agreement Sep 29 2016
Strong Brand Positioning Expected to Strengthen Teva’s Position Sep 29 2016
Teva Expects Significant Value Addition from Growth Markets Sep 29 2016
Teva’s Generic Business and Its Transformation in Europe Sep 29 2016
Teva’s Commercial Strategy May Be Successful across Europe Sep 28 2016
Teva’s Share of the US Generics Market Could Boost Its Stock Sep 28 2016
Teva Is Well Placed to Dominate the European Generics Market Sep 28 2016
Is Teva Positioned to Compete with the Likes of Mylan and Novartis? Sep 28 2016
Teva Announces Launch of Generic Epzicom® Tablets in the United States Sep 28 2016
Teva Pharmaceutical Still Dominates the Generic Market in Europe Sep 28 2016
A Look at Teva’s Dominance in the Biosimilar Space Sep 28 2016
Teva Is Well Positioned for New Trends in the US Generic Market Sep 27 2016
Teva’s OTC Business Is Playing out to Be a Key Growth Driver Sep 27 2016
This Strategy Could Boost Teva’s Growth Prospects Even More Sep 27 2016
The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alphabet and... Sep 27 2016
Teva’s Generic Value Chain Differentiates It from Its Peers Sep 27 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK